Table 3.
Multivariable Relationship Between CNS Medication Use and Recurrent Falls*
CNS Medication Use | Falls (2+ vs 0–1), Crude OR (95% CI) | Exact p Value | Falls (2+ vs 0–1), Adjusted OR (95% CI) | Exact p Value |
Use of 2+ agents | 2.45 (1.71–3.51) | <.0001 | 1.95 (1.35–2.81) | .0004 |
Use of 1 agent | 1.79 (1.41–2.27) | <.0001 | 1.55 (1.22–1.97) | .0004 |
No use | Reference | Reference | ||
Higher dose use (>3 SDD) | 3.47 (2.36–5.09) | <.0001 | 2.89 (1.96–4.25) | <.0001 |
Moderate dose use (1–3 SDD) | 2.15 (1.58–2.94) | <.0001 | 1.80 (1.31–2.47) | .0003 |
Lowest dose use (<1.0 SDD) | 1.68 (1.12–2.49) | .01 | 1.42 (0.95–2.15) | .5971 |
No use | Reference | Reference | ||
Long-term use | 1.48 (1.24–1.77) | <.0001 | 1.76 (1.35–2.28) | <.0001 |
Short-term use | 1.36 (1.11–1.67) | <.001 | 1.49 (1.11–2.01) | .008 |
No use | Reference | Reference |
Notes CI = confidence interval; CNS = central nervous system; OR = odds ratio; SDD = summated standard daily dose.
Multivariable Generalized Estimating Equation analyses adjusted for sociodemographic, health behavior, health status factors, and indications for CNS medications.